Pliant Therapeutics (PLRX) vs RenovoRx (RNXT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
RenovoRx (RNXT) has outperformed Pliant Therapeutics (PLRX) over the past year, gaining 12.3% versus a loss of 33.1%. Over five years, RNXT leads with a -77.1% price change compared with -94.5% for PLRX. RenovoRx is the larger company by market cap ($61.8 million vs $61.3 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | PLRX | RNXT |
|---|---|---|
| Share price | $0.99 | $1.37 |
| Market cap | $61.30M | $61.83M |
| 1-day change | -3.88% | -1.44% |
| YTD return | -18.85% | +63.10% |
| 1-year return | -33.11% | +12.30% |
| 5-year return | -94.50% | -77.09% |
| EPS (TTM) | $-1.44 | $-0.31 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $1.95 | $2.59 |
| 52-week low | $0.97 | $0.701 |
| Distance from 52-week high | -49.23% | -47.10% |
| Average volume | 488.25K | 753.57K |
| Shares outstanding | 61.92M | 45.13M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- RNXT has outperformed PLRX by 45.4 percentage points over the past year.
PLRX vs RNXT FAQ
Which is bigger, Pliant Therapeutics or RenovoRx?
RenovoRx (RNXT) is larger, with a market capitalization of $61.83M compared with $61.30M for Pliant Therapeutics (PLRX).
Which stock has performed better over the past year, PLRX or RNXT?
RNXT returned +12.30% over the past 12 months, compared with -33.11% for PLRX (price return, excluding dividends). Past performance does not predict future results.
Are Pliant Therapeutics and RenovoRx in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.